Table 5.
Baseline characteristics of the diabetic cohort.
| Number | 110 |
| Male, n (%) | 73 (66.4) |
| Age, years | 52.86 ± 10.32 |
| Body mass index, kg/m2 | 25.95 ± 4.64 |
| Smoking, n (%) | 33 (30.0) |
| Hypertension, n (%) | 59 (53.6) |
| Systolic blood pressure, mmHg | 133.66 ± 18.93 |
| Diastolic blood pressure, mmHg | 77.34 ± 12.77 |
| White blood cell (109/mL) | 6.37 ± 2.06 |
| Neutrophil (109/mL) | 3.82 ± 1.42 |
| Lymphocyte (109/mL) | 2.02 ± 0.63 |
| Monocyte (109/mL) | 0.44 ± 0.13 |
| Platelet (109/mL) | 186.38 ± 53.06 |
| hsCRP, mg/L | 0.77 (0.46–1.59) |
| Serum creatinine, μmol/L | 72.24 ± 16.60 |
| Blood urea nitrogen, mmol/L | 5.32 ± 1.59 |
| Uric acid, μmol/L | 330.26 ± 81.29 |
| eGFR, mL/min/1.73 m2 | 124.06 ± 22.56 |
| HbA1c, % | 7.60 (6.10–9.30) |
| Fasting glucose, mmol/L | 7.31 (5.65–10.68) |
| Postprandial glucose (2 h), mmol/L | 15.13 (10.46–18.71) |
| Fasting insulin, μIU/mL | 8.45 (4.31–15.12) |
| Postprandial insulin (2 h), μIU/mL | 38.31 (23.39–62.21) |
| Triglyceride, mmol/L | 1.87 (1.19–2.60) |
| Total cholesterol, mmol/L | 4.52 ± 1.16 |
| HDL cholesterol, mmol/L | 1.08 ± 0.32 |
| LDL cholesterol, mmol/L | 2.70 ± 0.92 |
| Apolipoprotein A, g/L | 1.28 ± 0.24 |
| Apolipoprotein B, g/L | 0.89 ± 0.25 |
| MHR | 11.00 (8.12–13.68) |
| Oral hypoglycemic drugs, n (%) | 77 (70.0) |
| Insulin, n (%) | 53 (48.2) |